Lifesciences@Work : We help scientists build their business

More success for Venture Challenge winner NightBalance: EUR 12.5 million financing to support commercial rollout in Europe and enter the U.S. market

NightBalance BV announced the completion of a EUR 12.5 million Series B financing round led by INKEF Capital and Gilde Healthcare Partners. Existing investors Thuja Capital, Health Innovation Fund, and Van Herk Ventures also participated. Dirk Kersten from INKEF, and Pieter van der Meer from Gilde will join the supervisory board, which will be chaired by Jan Keltjens and further strengthened with the appointment of Geoff Waters.

The proceeds of the Series B financing allow NightBalance to intensify and expand commercial efforts for its innovative Sleep Position Trainer in Europe, and to prepare for the company’s entry into the U.S. market. NightBalance is planning for further clinical studies in the U.S., guided by the leading sleep specialist Prof. Dr. David P. White from Harvard Medical School and former Chief Medical Officer for Philips Respironics. Also filing for U.S. Food and Drug Administration 510(k) clearance is being prepared.

Read the NightBalance press release.



NightBalance took part in the Venture Challenge Fall 2010 and won the Venture Challenge Award.



Check out the Dutch media coverage:


Check out the international media: